- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ongoing digitizer slump affects Lumisys Q3 results
Ongoing digitizer slump affects Lumisys Q3 resultsA slowdown in the film digitizer market continues to impact the financial performance of film digitizer company Lumisys. The Sunnyvale, CA-based firm reported a 2% increase in revenues for its
Ongoing digitizer slump affects Lumisys Q3 results
A slowdown in the film digitizer market continues to impact the financial performance of film digitizer company Lumisys. The Sunnyvale, CA-based firm reported a 2% increase in revenues for its third quarter.
Although sales showed signs of rebounding, revenues for the period (end-September) were $6 million, compared with $5.9 million for the third quarter in 1996. Net income was $616,000 compared with $817,000 in the same period last year.
The company also reported that the low-cost computed radiography reader it is developing for the medical market is on track for a late-1999 launch (PNN 5/97). Engineers at CompuRad will also be working on the CR project, once that company's acquisition is finalized.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
